Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: WFRF:(Vilhelmsson Anders) > Radioimmunotherapy ...

Details
MARC

Evans Axelsson, SusanLund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Urological cancer, Malmö,Lund University Research Groups (author)

Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.

Article/chapterEnglish2016

Publisher, publication year, extent ...

Elsevier BV,2016

Numbers

LIBRIS-ID:oai:lup.lub.lu.se:93a313fd-6737-45f1-b345-54c93ad47af2
https://lup.lub.lu.se/record/8824975URI
https://doi.org/10.1053/j.semnuclmed.2015.10.005DOI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:for swepub-publicationtype
Subject category:ref swepub-contenttype

Notes

Prostate cancer (PCa) is one of the most common cancers in men and is the second leading cause of cancer-related deaths in the USA. In the United States, it is the second most frequently diagnosed cancer after skin cancer, and in Europe it is number one. According to the American Cancer Society, approximately 221,000 men in the United States would be diagnosed with PCa during 2015, and approximately 28,000 would die of the disease. According to the International Agency for Research on Cancer, approximately 345,000 men were diagnosed with PCa in Europe during 2012, and despite more emphasis placed on early detection through routine screening, 72,000 men died of the disease. Hence, the need for improved therapy modalities is of utmost importance. And targeted therapies based on radiolabeled specific antibodies or peptides are a very interesting and promising alternative to increase the therapeutic efficacy and overall chance of survival of these patients. There are currently several preclinical and some clinical studies that have been conducted, or are ongoing, to investigate the therapeutic efficacy and toxicity of radioimmunotherapy (RIT) against PCa. One thing that is lacking in a lot of these published studies is the dosimetry data, which are needed to compare results between the studies and the study locations. Given the complicated tumor microenvironment and overall complexity of RIT to PCa, old and new targets and targeting strategies like combination RIT and pretargeting RIT are being improved and assessed along with various therapeutic radionuclides candidates. Given alone or in combination with other therapies, these new and improved strategies and RIT tools further enhance the clinical response to RIT drugs in PCa, making RIT for PCa an increasingly practical clinical tool.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

Vilhelmsson Timmermand, OskarLund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)immu-orv (author)
Bjartell, AndersLund University,Lunds universitet,Medicinska fakulteten,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Faculty of Medicine,Urological cancer, Malmö,Lund University Research Groups(Swepub:lu)kir-abj (author)
Strand, Sven-ErikLund University,Lunds universitet,Medicinsk strålningsfysik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical Radiation Physics, Lund,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)rafy-ses (author)
Elgqvist, JörgenLund University,Lunds universitet,Medicinsk strålningsfysik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical Radiation Physics, Lund,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)med-jeq (author)
Urologisk cancerforskning, MalmöForskargrupper vid Lunds universitet (creator_code:org_t)

Related titles

In:Seminars in Nuclear Medicine: Elsevier BV46:2, s. 165-1790001-2998

Internet link

Find in a library

Seminars in Nuclear Medicine (Search for host publication in LIBRIS)

To the university's database

Find more in SwePub

By the author/editor: Evans Axelsson, ...; Vilhelmsson Timm ...; Bjartell, Anders; Strand, Sven-Eri ...; Elgqvist, Jörgen

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Urology and Neph ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Articles in the publication: Seminars in Nucl ...

By the university: Lund University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se